Synthesis and in vitro anticancer activities of selenium N-heterocyclic carbene compounds

Article abstract of DOI:10.1111/cbdd.13900

Fourteen novel selenium N-heterocyclic carbene (Se-NHC) compounds derived from 4,5-diarylimidazole were designed, synthesized, and evaluated as antiproliferative agents. Most of them were more effective toward A2780 ovarian cancer cells than HepG2 hepatocellular carcinoma cells. Among them, the most active compound 2b was about fourfold more active than the positive control ebselen against A2780 cells. In addition, this compound displayed twofold higher cytotoxicity to A2780 cells than to IOSE80 normal ovarian epithelial cells. Further studies revealed that 2b could induce reactive oxygen species production, damage mitochondrial membrane potential, block the cells in the G0/G1 phase, and finally promote A2780 cell apoptosis.

Full text of DOI:10.1111/cbdd.13900

Article type
: Research Article
Synthesis and in vitro anticancer activities of selenium
N-heterocyclic carbene compounds
Sheng Huanga,1, Xinyu Shenga,1, Mianli Biana, Zhibin Yanga, Yunlong Lua* and Wukun Liua*
aJiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,
School of Pharmacy, School of Medicine & Holistic Integrative Medicine, Nanjing University of
Chinese Medicine, Nanjing, 210023, China
Corresponding Author
* Corresponding author. Nanjing University of Chinese Medicine, Nanjing, 210023, China
E-mail: yunlonglu12@njucm.edu.cn (Y. L.);
liuwukun0000@hotmail.com, liuwukun0000@njucm.edu.cn (W. L.)
Tel: +86-25-85811357
Author Contributions
1 Sheng Huang and Xinyu Sheng contributed equally to this work.
Abstract
Fourteen novel selenium N-heterocyclic carbene (Se-NHC) compounds derived from
4,5-diarylimidazole were designed, synthesized, and evaluated as antiproliferative agents. Most of
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/CBDD.13900
This article is protected by copyright. All rights reserved

them were more effective towards A2780 ovarian cancer cells than HepG2 hepatocellular
carcinoma (HCC) cells. Among them, the most active compound 2b was about 4-fold more active
than the positive control ebselen against A2780 cells. In addition, this compound displayed 2-fold
higher cytotoxicity to A2780 cells than to IOSE80 normal ovarian epithelial cells. Further studies
revealed that 2b could induce reactive oxygen species (ROS) production, damage mitochondrial
membrane potential (MMP), block the cells in the G0/G1 phase, and finally promote A2780 cell
apoptosis.
Keywords: N-heterocyclic carbene; selenium compounds; ovarian cancer; antitumor; apoptosis
1. Introduction
Cancer is one of the diseases with the highest mortality rate in the world. Among them, ovarian
cancer is the main cause of death from all gynecological tumors, and chemotherapy is the main
method for the treatment of metastatic ovarian cancer (Kala et al., 2014). However, commonly
used chemotherapeutic drugs are often limited in clinic due to highly non-specific cytotoxicity and
adverse side effects. Meanwhile, intrinsic and acquired drug resistance is also one of the clinical
disadvantages of chemotherapeutics (Siegel, Naishadham, & Jemal, 2013). Therefore, the
development of new chemotherapeutic drugs is urgent (Banerjee & Kaye, 2013).
Selenium (Se), as an essential micronutrient, plays a significant role in human health
(Hosnedlova et al., 2017; Ibrahim, Kerkadi, & Agouni, 2019). In recent years, researchers focused
on the potential therapeutic effects of Se in cancer treatment (An, Wang, et al., 2018). Among
them, more and more organoselenium derivatives were developed and studied for their lower
toxicity compared to inorganic Se compounds (Reich & Hondal, 2016). Several organoselenium
compounds, including ebselen (Se1), ethaselen (Se2), and Se N-heterocyclic carbene (NHC)
compounds (Se3-6) (Figure 1) have been shown to inhibit cancer cell growth in vitro and in vivo
(Engman et al., 1997; Kamal et al., 2019; Lai et al., 2018; Nguyen et al., 2011; Wang et al., 2012;
Yang et al., 2009; Zeng, Deng, Sang, Zhao, & Chen, 2018). It was also reported that they have
synergistic effects in combination with chemotherapy drugs (Ip, Lisk, & Ganther, 1998; Z. Li et al.,
2009). Therefore, organoselenium compounds with different scaffolds have been used as
chemotherapeutic agents attributed to their significant anticancer bioactivity (Sanmartin, Plano, &
This article is protected by copyright. All rights reserved

Palop, 2008).
O
O
Se
N
N
Se
N
Se
O
Se1 (Ebselen)
Se2 (Ethaselen)
O
N
N
N
N
N
N
N
Se
Se
Se
N
Se
Se5
Se3
Se4
Se6
Fig 1. The structure of compounds Se1-Se6.
NHC was widely used in organic or inorganic chemistry for drug design. As σ-donor or
π-acceptor, NHC could easily combine with some metal elements to form stable and
biologically active complexes (Garcia-Garcia, Martinez, Sanjuan, Fernandez-Rodriguez, &
Sanz, 2011; Gautier & Cisnetti, 2012; Liu & Gust, 2013; Mercs & Albrecht, 2010; Teyssot et
al., 2009). Different transition metals including gold (Casini, Sun, & Ott, 2018; Hickey et al.,
2008; Liu, Bensdorf, & Proetto, 2011, 2012; Long et al., 2020; Meyer et al., 2014; Zou, Lum,
Chui, & Che, 2013), silver (Liu, Bensdorf, Hagenbach, et al., 2011), iridium (Gothe, Marzo,
Messori, & Metzler-Nolte, 2015; Y. Li et al., 2015; C. Yang et al., 2016), platinum (Harlepp
et al., 2019; Rothemund et al., 2020; Tham, Babak, & Ang, 2020) and rhodium (Fan, Bian,
Hu, & Liu, 2019) have been designed as metal-based NHC complexes for chemotherapy,
and many of them exhibited highly effective anticancer activities both in vivo and in vitro.
In our previous work, gold(I) and silver(I) NHC complexes derived from
4,5-diarylimidazole showed high inhibitory effects in MCF-7 and MDA-MB 231 breast
cancer as well as HT-29 colon cancer cells (Liu, Bensdorf, Hagenbach, et al., 2011; Liu,
Bensdorf, & Proetto, 2011; Liu et al., 2012). Preliminary structure activity relationships
This article is protected by copyright. All rights reserved

(SAR) study demonstrated that the -F and -OMe groups at the para-position of aromatic
rings increased the bioactivity of gold(I) NHC complexes in cancer cells. The substituents
at the nitrogen atoms, the oxidation state of the metal, and the anionic counterion on these
complexes also played significant roles in regulating the bioactivity of them.
Recently, we found that both iodo (1,3-diethyl-4,5-bis(4-methoxyphenyl)
imidazole-2-ylidene)
gold(I)
complex
and
chloride
(η2,η2-cycloocta-1,5-diene)
(4,5-bis(4-fluorophenyl)-1,3-diethylimidazol-2-ylidene) rhodium(I) complex showed strong
antiproliferative activity against hepatocellular carcinoma (HCC) cells (Bian et al., 2020;
Fan et al., 2019). The mechanism study showed that these NHC complexes can powerfully
inhibit the activity of thioredoxin reductase (TrxR). The level of intracellular reactive oxygen
species (ROS) was thereby increased, and it damaged the mitochondrial membrane
potential (MMP) and induced cell apoptosis. In vivo anticancer studies furtherly showed
that gold(I) and rhodium(I) NHC complexes can significantly repress tumor growth in a
HepG2 xenograft mouse model and ameliorate liver injury caused by CCl4 in chronic HCC.
In the continuation of our studies, fourteen novel Se-NHC compounds derived from
4,5-diarylimidazole were designed and synthesized, the antitumor activity of these
compounds were subsequently evaluated. The 4,5-diarylimidazole salts were used as raw
material to obtain Se-NHC compounds and antitumor activities of Se-NHC compounds
were tested in HepG2 cells, A2780 cells, and IOSE80 cells by MTT assay. Bioactivity
research revealed that the most promising compound 2b can induce intracellular ROS
accumulation and promote apoptosis in A2780 cells.
2. Experimental sections
2.1. reagents and methods
All reagents used in the synthesis were obtained from Energy Chemical Company (China)
without further purification. The deuterated solvent was obtained from Cambridge Isotope Lab Inc.
(CIL). Purified TrxR (rat liver) and ct-DNA were obtained from Sigma-Aldrich Co.; JC-1 assay kit
was obtained from APExBio (China). Apotosis kit, ROS detection kit and GSH and GSSG Assay
This article is protected by copyright. All rights reserved

Kit were obtained from Beyotime (China). DNA content kit was obtained from Key Gen Biotech
(Nanjing, China).
HPLC grade solvents and Millipore (> 18.2 MU) double distilled water were used for the
1
preparation of all spectroscopic and biological research solutions. The H NMR and 13C NMR
spectra were measured by Bruker Avance III HD 500 MHz nuclear magnetic resonance
instrument; low resolution mass spectrometry was measured by Aglient 1290-6125 single
quadrupole LC/MS spectrometer, ESI ion Source determination; X-ray single crystal structure data
collected by BRUKER Smart APEX II CCD; UV/Vis spectra were measured by Shimadzu UV2400
spectrophotometer. Fluorescent microscopy was performed by a Leica DMi8 fluorescence
microscope. Flow Cytometry was performed by BD Accuri™ C6 Plus and Beckman Gallios.
Microplate detection was performed by Tecan M1000 Pro.
2.2. Synthesis of selenium compounds
2.2.1. The synthesis of 1a-1n.
The synthesis of compounds 1a, 1b, 1e-1i and 1k-1n has been reported previously (Fan et al.,
2019) . The new analogues 1c, 1d and 1j were prepared by the same route, and their data from
1H NMR spectra were listed below.
3-benzyl-1-ethyl-4,5-bis(4-methoxyphenyl)-1H-imidazol-3-ium bromide 1c: 1H NMR (500 MHz,
DMSO) δ 9.68 (s, 1H, NCHN), 7.40-7.27 (m, 5H, ArPhH), 7.23-7.06 (m, 4H, ArPhH), 6.97 (dd, J =
36.9, 8.6 Hz, 4H, ArPhH), 5.37 (s, 2H, NCH2Ar), 4.12 (q, J = 7.2 Hz, 2H, NCH2CH3), 3.76 (d, J =
10.2 Hz, 6H, OCH3), 1.32 (t, J = 7.2 Hz, 3H, NCH2CH3).
1
1-ethyl-3-(2-methoxyethyl)-4,5-bis(4-methoxyphenyl)-1H-imidazol-3-ium bromide 1d: H NMR
(500 MHz, CDCl3) δ 10.32 (s, 1H, NCHN), 7.19-7.07 (m, 4H, ArPhH), 6.89-6.79 (m, 4H, ArPhH),
4.36 (t, J = 5.0 Hz, 2H, NCH2CH2), 4.22 (q, J = 7.3 Hz, 2H, NCH2CH3), 3.73 (t, J = 3.7 Hz, 8H,
ArOCH3, NCH2CH2), 3.31 (s, 3H, OCH3), 1.43 (t, J = 7.3 Hz, 3H, NCH2CH3).
This article is protected by copyright. All rights reserved

1-ethyl-4,5-bis(4-fluorophenyl)-3-(3-hydroxypropyl)-1H-imidazol-3-ium bromide 1j: 1H NMR (500
MHz, DMSO) δ 9.56 (s, 1H, NCHN), 7.51 (ddd, J = 8.5, 5.4, 1.5 Hz, 4H, ArPhH), 7.33 (td, J = 8.8,
2.2 Hz, 4H, ArPhH), 4.67 (t, J = 5.0 Hz, 1H, -OH), 4.21 – 4.04 (m, 4H, NCH2CH2CH2OH, NCH2CH3),
3.39 (dd, J = 11.1, 5.7 Hz, 2H, NCH2CH2CH2OH), 1.84-1.75 (m, 2H, NCH2CH2CH2OH), 1.31 (t, J =
7.3 Hz, 3H, NCH2CH3).
2.2.2. General procedure for the synthesis of 2a-2m
1a-1m (0.83 mmol, 1 eq) was dissolved in dry THF (10 mL), KOtBu (1.66 mmol, 2 eq), selenium
powder (1.24 mmol, 1.5 eq) were added, and the solution was stirred under ice bath for 5 hours.
The products (2a-2m) were isolated by column chromatography on silica gel (mobile phase:
PE/EA, 20:1). The samples were eluted with acetonitrile/H2O mixture at a constant flow rate. The
purity of all Se-NHC compounds is greater than 95% by HPLC analysis (Figure S5).
1
1,3-diethyl-4,5-bis(4-methoxyphenyl)-imidazole-2-selenone 2a: white powder (yield 60%). H
NMR (500 MHz, CDCl3) δ 7.11 (d, J = 8.6 Hz, 4H, ArPhH), 6.84 (d, J = 8.6 Hz, 4H, ArPhH), 4.21 (q, J
13
= 7.1 Hz, 4H, NCH2CH3), 3.79 (s, 6H, OCH3), 1.24 (t, J = 6.8 Hz, 6H, NCH2CH3). C NMR (126
MHz, CDCl3) δ 159.90 (Se=C), 152.81, 131.86, 120.37, 114.08 (ArPhC), 129.56 (NC=CN), 55.22
(ArOCH3), 42.50 (NCH2CH3), 14.44(NCH2CH3). ESI-MS (+) [m/z]: 416.8 [M+H]+. Purity: 95.5% (by
HPLC). Retention time tR = 15.888 min.
1-ethyl-4,5-bis(4-methoxyphenyl)-3-(2,4,6-trimethylbenzyl)-imidazole-2-selenone 2b: white
powder (yield 66.7%). 1H NMR (500 MHz, CDCl3) δ 7.07 (d, J = 8.4 Hz, 2H, ArPhH), 6.81 (d, J = 8.5
Hz, 2H, ArPhH), 6.63 - 6.54 (m, 4H, ArPhH), 6.47 (d, J = 8.5 Hz, 2H, ArPhH), 5.58 (s, 2H, NCH2Ar),
4.27 (d, J = 7.1 Hz, 2H, NCH2CH3), 3.78 (s, 3H, ArOCH3), 3.71 (s, 3H, ArOCH3), 2.17 (s, 3H,
ArCH3), 1.94 (s, 6H, ArCH3), 1.28 - 1.25 (m, 3H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 155.40
(Se=C), 159.88, 159.51, 136.88, 136.61, 131.82, 131.63,130.31, 130.25, 129.01, 120.42, 120.24,
113.95, 113.00 (ArPhC), 130.19 (NC=CN), 55.18, 55.17(ArOCH3), 48.16 (NCH2Ar), 42.83
(NCH2CH3), 20.67, 20.33 (ArCH3), 14.46 (NCH2CH3). ESI-MS (+) [m/z]: 441.2 [M-Se]+. Purity:
99.2% (by HPLC). Retention time tR = 11.764 min.
This article is protected by copyright. All rights reserved

1-benzyl-3-ethyl-4,5-bis(4-methoxyphenyl)-imidazole-2-selenone 2c: white powder (yield
63.1%). 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 5.0 Hz, 3H, ArPhH), 7.16 - 7.05 (m, 4H, ArPhH),
6.86 (dd, J = 8.1, 4.9 Hz, 4H, ArPhH), 6.72 (d, J = 8.5 Hz, 2H, ArPhH), 5.47 (s, 2H, NCH2Ar), 4.29 (q,
J = 7.0 Hz, 2H, NCH2CH3), 3.78 (d, J = 15.7 Hz, 6H, ArOCH3), 1.30 (t, J = 7.1 Hz, 3H, NCH2CH3).
13C NMR (126 MHz, CDCl3) δ 155.20 (Se=C), 159.95, 159.88, 136.65, 132.07, 131.88, 128.31,
127.56, 127.36, 120.25, 120.20, 114.10, 113.81, 130.07(ArPhC), 129.73 (NC=CN),55.24, 55.21
(ArOCH3), 50.66 (NCH2Ar), 42.98 (NCH2CH3), 14.48 (NCH2CH3). ESI-MS (+) [m/z]: 339.2 [M-Se]+,
479.0 [M+H]+. Purity: 96.1% (by HPLC). Retention time tR = 16.628 min.
1-ethyl-3-(2-methoxyethyl)-4,5-bis(4-methoxyphenyl)-imidazole-2-selenone 2d: white powder
(yield 65%). 1H NMR (500 MHz, CDCl3) δ 7.14 (dd, J = 15.6, 8.7 Hz, 4H, ArPhH), 6.85 (dd, J = 8.6,
7.7 Hz, 4H, ArPhH), 4.33 (t, J = 6.0 Hz, 2H, NCH2CH2), 4.23 (q, J = 7.1 Hz, 2H, NCH2CH3), 3.85 -
3.75 (m, 8H, ArOCH3, NCH2CH2), 3.23 (s, 3H, OCH3), 1.26 (t, J = 7.1 Hz, 3H, NCH2CH3). 13C NMR
(126 MHz, CDCl3) δ 153.44 (Se=C), 159.91, 159.87, 132.36, 131.93, 120.39, 120.24, 114.08,
113.92 (ArPhC), 130.53, 129.37 (NC=CN), 69.69 (CH2OCH3), 58.67 (CH2OCH3), 55.24, 55.21
(ArOCH3), 46.37 (NCH2CH2), 42.62(NCH2CH3), 14.41(NCH2CH3). ESI-MS (+) [m/z]: 367.2 [M-Se]+,
447.2 [M+H]+. Purity: 95.6% (by HPLC). Retention time tR = 15.870 min.
1
4,5-bis(4-bromophenyl)-1,3-diethyl-imidazole-2-selenone 2e: white powder (yield 86%). H
NMR (500 MHz, CDCl3) δ 7.54-7.48 (m, 4H, ArPhH), 7.11-7.02 (m, 4H, ArPhH), 4.24 (q, J = 7.1 Hz,
4H, NCH2CH3), 1.27 (t, J = 7.1 Hz, 6H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 155.12 (Se=C),
132.19, 131.94, 126.84, 123.80 (ArPhC), 128.89 (NC=CN), 42.72 (NCH2CH3), 14.39 (NCH2CH3).
ESI-MS (+) [m/z]: 433.0 [M-Se]+. Purity: 97.1% (by HPLC). Retention time tR = 11.501 min.
1
1,3-diethyl-4,5-bis(4-fluorophenyl)-imidazole-2-selenone 2f: white powder (yield 56.2%). H
NMR (500 MHz, CDCl3) δ 7.22-7.16 (m, 4H, ArPhH), 7.07 (dd, J = 11.8, 5.4 Hz, 4H, ArPhH), 4.24 (q,
J = 7.1 Hz, 4H, NCH2CH3), 1.27 (t, J = 7.1 Hz, 6H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ
This article is protected by copyright. All rights reserved

154.39 (Se=C), 164.02, 162.03, 132.46, 132.39, 124.05, 124.02, 116.14, 115.97 (ArPhC), 129.03
(NC=CN), 42.65 (NCH2CH3), 14.38 (NCH2CH3). ESI-MS (+) [m/z]: 415.5 [M+Na]+, 313.8 [M-Se]+.
Purity: 98.0% (by HPLC). Retention time tR = 10.628 min.
1-ethyl-4,5-bis(4-fluorophenyl)-3-(2,4,6-trimethylbenzyl)-imidazole-2-selenone 2g: white powder
(yield 40.4%). 1H NMR (500 MHz, CDCl3) δ 7.17 - 7.08 (m, 2H, ArPhH), 7.04 - 6.96 (m, 2H, ArPhH),
6.64 (dd, J = 6.9, 3.9 Hz, 4H, ArPhH), 6.58 (s, 2H, ArPhH), 5.60 (s, 2H, NCH2Ar), 4.27 (q, J = 7.1 Hz,
2H, NCH2CH3), 2.17 (s, 3H, ArCH3), 1.93 (s, 6H, ArCH3), 1.27 (t, J = 5.5 Hz, 3H, NCH2CH3). 13C
NMR (126 MHz, CDCl3) δ 156.70 (Se=C), 163.95, 163.63, 161.96, 161.64, 137.13, 136.86, 129.94,
129.73, 129.61, 129.08, 123.90, 123.87, 123.85, 123.82, 115.95, 115.78, 114.73, 114.56 (ArPhC),
132.40, 132.34, 132.14, 132.07 (NC=CN), 48.27 (NCH2Ar), 42.96 (NCH2CH3), 29.68, 20.65, 20.27
(ArCH3), 14.39 (NCH2CH3). ESI-MS (+) [m/z]: 417.0 [M-Se]+. Purity: 95.2% (by HPLC). Retention
time tR = 18.680 min.
1-benzyl-3-ethyl-4,5-bis(4-fluorophenyl)-imidazole-2-selenone 2h: white powder (yield 99.8%).
1H NMR (500 MHz, CDCl3) δ 7.26-7.16 (m, 5H, ArPhH), 7.05 (t, J = 8.6 Hz, 4H, ArPhH), 6.90 (d, J =
6.7 Hz, 4H, ArPhH), 5.48 (s, 2H, NCH2Ar), 4.30 (d, J = 7.1 Hz, 2H, NCH2CH3), 1.31 (t, J = 7.1 Hz,
3H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 156.84 (Se=C), 164.04, 163.98, 162.05, 161.99,
136.27, 129.51, 129.22, 128.40, 127.57, 127.47, 123.91, 123.88, 123.84, 123.81, 116.12, 115.95,
115.76, 115.59 (ArPhC), 132.67, 132.60, 132.45, 132.38 (NC=CN), 50.87 (NCH2Ar), 43.11
(NCH2CH3), 14.37 (NCH2CH3). ESI-MS (+) [m/z]: 454.9 [M+H]+, 476.9 [M+Na]+. Purity: 95.8% (by
HPLC). Retention time tR = 10.923 min.
1-ethyl-4,5-bis(4-fluorophenyl)-3-(2-methoxyethyl)-imidazole-2-selenone 2i: white powder (yield
40.4%). 1H NMR (500 MHz, CDCl3) δ 7.21 (ddd, J = 19.3, 8.3, 5.4 Hz, 4H, ArPhH), 7.09 - 6.99 (m,
4H, ArPhH), 4.31 (t, J = 5.6 Hz, 2H, NCH2CH2), 4.24 (q, J = 7.1 Hz, 2H, NCH2CH3), 3.81 (t, J = 5.6
13
Hz, 2H, NCH2CH2), 3.22 (s, 3H, OCH3),1.27 (t, J = 7.1 Hz, 3H, NCH2CH3). C NMR (126 MHz,
CDCl3) δ 154.89 (Se=C), 164.01, 163.99, 162.02, 162.00, 133.10, 133.03, 132.53, 132.46, 124.12,
This article is protected by copyright. All rights reserved

124.10, 123.95, 123.92, 116.09, 115.92, 115.81, 115.64 (ArPhC), 130.18, 128.74 (NC=CN), 69.65
(CH2OCH3), 58.61 (CH2OCH3), 46.77 (NCH2CH2), 42.69 (NCH2CH3), 14.31 (NCH2CH3). ESI-MS
(+) [m/z]: 422.9 [M+H]+, 343.0 [M-Se]+. Purity: 99.3% (by HPLC). Retention time tR = 15.602 min.
1-ethyl-4,5-bis(4-fluorophenyl)-3-(3-hydroxypropyl)-imidazole-2-selenone 2j: white powder
(yield 56%). 1H NMR (500 MHz, CDCl3) δ 7.24 - 7.15 (m, 4H, ArPhH), 7.07 (td, J = 8.5, 1.4 Hz, 4H,
ArPhH), 4.46 - 4.41 (m, 2H, NCH2CH2CH2OH), 4.24 (q, J = 7.1 Hz, 2H, NCH2CH3), 3.75 (t, J = 7.2
Hz, 1H, -OH), 3.51 (dd, J = 11.3, 6.5 Hz, 2H, NCH2CH2CH2OH), 1.61 (dt, J = 11.4, 5.8 Hz, 2H,
NCH2CH2CH2OH), 1.26 (t, J = 7.1 Hz, 3H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 154.84
(Se=C),164.09, 162.10, 132.50, 132.47, 132.43, 132.40, 123.70, 123.67, 123.65, 123.62, 116.28,
116.23, 116.10, 116.05 (ArPhC), 129.70, 129.17 (NC=CN), 57.19 (NCH2CH2CH2OH), 43.60
(NCH2CH2CH2OH), 42.96 (NCH2CH3), 32.29 (NCH2CH2CH2OH), 14.36 (NCH2CH3). ESI-MS (+)
[m/z]: 423.0 [M+H]+, 343.2 [M-Se]+. Purity: 98.7% (by HPLC). Retention time tR = 14.745 min.
1
4,5-di([1,1'-biphenyl]-4-yl)-1,3-diethyl-imidazole-2-selenone 2k: white powder (yield 77.3%). H
NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 8H, ArPhH), 7.45 (t, J = 7.5 Hz, 4H, ArPhH), 7.38 (t, J
= 7.4 Hz, 2H, ArPhH), 7.32 (d, J = 8.1 Hz, 4H, ArPhH), 4.33 (q, J = 7.0 Hz, 4H, NCH2CH3), 1.34 (t, J
13
= 7.1 Hz, 6H, NCH2CH3). C NMR (126 MHz, CDCl3) δ 154.08 (Se=C), 141.71, 139.86, 130.93,
128.89, 127.83, 127.33, 127.06, 126.99 (ArPhC), 129.69 (NC=CN), 42.75 (NCH2CH3), 14.53
(NCH2CH3). ESI-MS (+) [m/z]: 429.0 [M-Se]+. Purity: 99.0% (by HPLC). Retention time tR =
19.544 min.
1,3-diethyl-4,5-bis(4'-fluoro-[1,1'-biphenyl]-4-yl)-imidazole-2-selenone 2l: white powder (yield
1
46.0%). H NMR (500 MHz, CDCl3) δ 7.55 (dd, J = 9.1, 5.1 Hz, 8H, ArPhH), 7.34 - 7.29 (m, 4H,
ArPhH), 7.14 (t, J = 8.6 Hz, 4H, ArPhH), 4.32 (q, J = 7.0 Hz, 4H, NCH2CH3), 1.33 (t, J = 7.0 Hz, 6H,
NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 154.23 (Se=C), 163.72, 161.75, 140.74, 135.99, 135.97,
130.99, 128.65, 128.58, 127.20, 127.07, 115.92, 115.75 (ArPhC), 129.60 (NC=CN), 42.75
(NCH2CH3), 14.53 (NCH2CH3). ESI-MS (+) [m/z]: 465.2 [M-Se]+. Purity: 97.2% (by HPLC).
This article is protected by copyright. All rights reserved

Retention time tR = 11.632 min.
1,3-diethyl-4,5-bis(4'-methoxy-[1,1'-biphenyl]-4-yl)-imidazole-2-selenone 2m: white powder
(yield 84.4%). 1H NMR (500 MHz, DMSO-d6) δ 7.66 (dd, J = 11.7, 8.5 Hz, 8H, ArPhH), 7.46 (d, J =
8.2 Hz, 4H, ArPhH), 7.01 (d, J = 8.7 Hz, 4H, ArPhH), 4.13 (q, J = 6.9 Hz, 4H, NCH2CH3), 3.79 (s, 6H,
OCH3), 1.16 (t, J = 7.0 Hz, 6H, NCH2CH3). 13C NMR (126 MHz, CDCl3) δ 153.82 (Se=C), 159.54,
141.25, 132.33, 130.91, 128.05, 126.79, 126.40, 114.33 (ArPhC), 129.73 (NC=CN), 55.36
(ArOCH3), 42.72 (NCH2CH3), 14.55 (NCH2CH3). ESI-MS (+) [m/z]: 489.2 [M-Se]+. Purity: 97.2%
(by HPLC). Retention time tR = 11.949 min.
2.2.3. Synthesis of 2n
1,3-diethyl-imidazole-2-selenone 2n: 1n (686 mg, 3.31 mmol) was dissolved in water (20 mL).
Selenium powder (400 mg, 5.06 mmol) along with Na2CO3 (920 mg, 6.66 mmol) were then added
and the reaction mixture was heated to reflux for 5 h. The reaction mixture was filtered through
celite, washed with distilled water and was extracted using ethyl acetate. A white powder (403 mg,
1
yield 60%) was obtained under vacuum. H NMR (500 MHz, CDCl3) δ 6.89 (d, J = 2.0 Hz, 2H,
13
CH=CH), 4.18 (qd, J = 7.2, 1.9 Hz, 4H, NCH2CH3), 1.39 (td, J = 7.3, 2.0 Hz, 6H, NCH2CH3). C
NMR (126 MHz, CDCl3) δ 154.06 (Se=C), 118.07 (NC=CN), 44.64 (NCH2CH3), 14.46 (NCH2CH3).
ESI-MS (+) [m/z]: 204.0 [M+H] +, 125.5 [M-Se]+. Purity: 98.7% (by HPLC). Retention time tR =
11.452 min.
2.3. Cell culture
Human hepatocellular carcinoma cell line HepG2 was obtained from the American Type Culture
Collection (ATCC) and maintained in DMEM (Gibco, USA) supplemented with 10% FBS and 1%
penicillin/streptomycin. Human ovarian cancer cell line A2780 and Human immortalized ovarian
epithelial cell line IOSE80 were purchased from iCell Bioscience Inc (Shanghai, China) and were
grown in RPMI 1640 medium (Gibco, USA) supplemented with 10% FBS and 1%
penicillin/streptomycin. All cells reached a maximum of 20 passages during these studies.
This article is protected by copyright. All rights reserved

2.4. Cell viability assay
2a-2n and ebselen were dissolved in DMF to prepare a 20 mM stock solution. Then, the
solutions were diluted with cell culture medium before treatment. Cells in the logarithmic growth
phase were cultured into 96-well plates overnight and then incubated with the 2a-2n and ebselen
at 37 °C and 5% CO2 for 72 hours. The cell viability was detected by the MTT assay. MTT (5
mg/mL in PBS solution) were added to each well. After incubating for four hours, the medium was
removed and 200 μL DMSO were added to dissolve formazan. Finally, the absorbance data of
each well was detected at 490 nm after shaking on the shaker for 10 minutes.
2.5. Isolated TrxR enzyme assay
Different concentrations of 2b (5 μM, 10 μM, 20 μM, 40 μM) and TrxR were successively
dissolved in reaction buffer, DMF was used as a control. 200 μL of the reaction buffer and 25 μL of
NADPH solution were then added to each well. Subsequently, 25 μL of DTNB (20 mM) solution
was dropwise added to each well to start the reaction. After mixing, the absorbance data were
recorded at 405 nm every 10 s for the first six minutes by microplate reader. The calculation
method was according to our previously published methods (Fan et al., 2019).
2.6. Apoptosis assays
A2780 cells were incubated with 0.1% DMF or 2b in different concentrations for 48 h. Then
A2780 cells were stained with Annexin V-FITC/PI regent before detecting the double fluorescent
signal by flow cytometry (BD Accuri™ C6).
2.7. Cell cycle arrest
A2780 cells (6 x 105 cells/well) were cultured in 6-well plates for 24 h. Then, the cells were
treated with 2b for another 24 h. DMF group was as a control. Cells were harvested and
processed using the DNA content kit (Nanjing Key Gen Biotech) according to the manufacturer’s
This article is protected by copyright. All rights reserved

protocol. Stage of the cell cycle was determined by flow cytometry (Beckman Gallios).
2.8. Intracellular ROS measurement
The fluorescent probe DCFH-DA (Beyotime, China) were used to assess the intracellular ROS
generation. A2780 cells (1 × 105) were evenly seeded in 6-well plate and cultured overnight. After
adhering to the wall, cells were treated with DMF or indicated concentrations of 2b and cultured for
another 6 h. Then, cells were rinsed gently with PBS and DCFH-DA ROS probe (Beyotime, China)
was loaded by the kit method. At last, cells were washed twice with PBS before visualizing
intracelluar fluorescence generation by a fluorescent microscopy (Leica DMi8) under 200
×magnification.
For quantitative measurement of ROS production in A2780 and IOSE80 cells, cells were plated
in 96-well plate at a density of 8000 cells per well, incubated for 24 h before treatment with the
indicated concentrations of 2b for 6 h. Then, cells were treated with fluorescent probe DCFH2-DA
by the same method mentioned above and the fluorescence intensity was tested by a microplate
reader (Tecan M1000 Pro).
2.9. Assessment of MMP
MMP (mitochondrial membrane potential) was detected by the JC-1 dye. A2780 cells were
cultured in a 6-well plate and washed by PBS. Then cells were stained with 5 μM JC-1 for 15min in
darkness. Then remained dye was washed by PBS and red/green fluorescence were observed by
a fluorescent microscopy (Leica DMi8).
2.10. Intracellular GSH/GSSG ratio Measurement
After incubating with 2b for 24 h in A2780 cells, GSH and GSSG Assay Kit (Beyotime, China)
was used to measure the ratio of GSH/GSSG.
2.11. UV-Vis spectral analysis
2b was dissolved in DMF in a concentration of 20 mM and ct-DNA was dissolved in PBS buffer
This article is protected by copyright. All rights reserved

with pH 7.2 in a concentration of 1.152 mM. 2b was diluted 4000 times to obtain a solution in a
concentration of 20 μM. Next, the ct-DNA solution was gradually dropped into 2b solution
mentioned above. The data of absorption spectra were recorded by spectrophotometer.
2.12. Circular dichroism spectral analysis
2b was incubated with ct-DNA (1.0 × 10-5 M) at 37 °C overnight. The data of 2b with different
concentrations (0, 0.05, 0.1, 0.2, 0.5, 0.8, 1.0, 2.0 × 10-5 M) was recorded range from 235 nm to
300 nm by CD spectrometer.
2.13. Stability analysis
1
2b was dissloved in 10% deuteroxide + 90% dimethyl sulfoxide-d6 and then detected H NMR
spectra in 7 days.
2.14. Interaction with GSH and NAC
2b (2 mM) and GSH (2 mM) were dissloved in dimethyl sulfoxide-d6 and then detected 1H NMR
spectra in 7 days.
2b (2 mM) and NAC (2 mM) were dissloved in 50% acetonitrile-d3 + 50% dimethyl sulfoxide-d6
and then detected 1H NMR spectra in 7 days.
2.15. X-ray crystallographic analysis
The data of 2b and 2l were collected at 193(2) K and 292(2) K on a BRUKER Smart APEX II
CCD area-detector diffractometer, respectively. CCDC 2051718 and 2052871. DOI:
10.5517/ccdc.csd.cc26vzgj and 10.5517/ccdc.csd.cc26x5nz.
3. Results and discussion
3.1. Chemistry
This article is protected by copyright. All rights reserved

R1
R1
R1
R1
R1
R1
R1
R1
R1
R1
R1
ii
iv
vi
i
iii
N
R2
N
N
R2
N
CHO
Br
NH
N
N
N
O
HO
Br
Se
2a-2j
Br
1a-1j
R1
R1
R1
R1
R1
R1
iv
v
vi
N
R2
N
N
N
iv
N
N
N
R2
N
Se
2k-2m
Br
1k-1m
N
R2
N
N
vii
R2
N
N
N
Br
1n
Se
2n
compounds
R2
Et
compounds
R1
R1
R2
1a, 2a
F
F
F
OMe
1h, 2h
1b, 2b
1i, 2i
1j, 2j
OMe
OMe
OMe
Br
MeO
HO
1c, 2c
1d, 2d
MeO
Et
Et
Et
1k, 2k
1e, 2e
1f, 2f
Et
Et
Et
1l, 2l
F
1m, 2m
F
MeO
1g, 2g
1n, 2n
F
-
Scheme 1. i: thiamine hydrochloride, rt, ii: formamide, 210 °C, reflux, iii: NaH, ethyl bromide, THF,
reflux, iv: R2Br, CH3CN, reflux, 85°C, 2 d, v: K2CO3, Pd(PPh3)4, ethanol/ H2O/acetone (3:2:3), reflux, 95
°C, 2 d, vi: Se, KOtBu, THF, 0 °C, 5 h, vii: Se, Na2CO3, H2O, 100 °C, reflux, 5 h.
The 4,5-diarylimidazole salts 1a-1n in the Scheme 1 were synthesized according to our
previously published methods (Fan et al., 2019). In general, benzoin condensation
reactions were carried out to obtain diketone derivatives by anisaldehyde analogues, and
then the products were cyclized with formamide to obtain imidazole derivatives. Two-step
substitution reactions of the imidazole rings were then carried out to obtain
4,5-diarylimidazole salts. In addition, biphenyl imidazole compounds were first obtained by
This article is protected by copyright. All rights reserved

suzuki coupling reaction. Subsequently, the imidazole salt ligands (1a-1n) were dissolved
in tetrahydrofuran (THF) and reacted with elemental Se powder under the alkaline
condition of potassium tert-butoxide (KOtBu) to obtain the corresponding Se-NHC
compounds 2a-2n (Weiss, Reichel, Handke, & Hampel, 1998). The obtained compounds
1
13
were characterized by H NMR, C NMR, and mass spectra (Figure S4 and S6). The
chemical shift value of the carbene H-atoms for 2a-n disappeared compared to
1
4,5-diarylimidazole salts 1a-n in the H NMR spectra. In 13C NMR spectra, the chemical
shift value of C=Se for 2a-n was in the range of 150-160 ppm which was increased by
approximately 15-25 ppm compared to the 4,5-diarylimidazole salts 1a-n. In addition,
positive mode ESI mass spectrometry showed that Se-NHC compounds documented a
peak corresponding to the [M-Se]+ fragment for 2a-2n.
3.2. Crystal Structure Description
Fig 2. The crystal structure of 2b (left) and 2l (right).
To gain insight into the structural information of these compounds, 2b and 2l were
isolated as single crystals and characterized by X-ray diffraction. The molecular structures
of 2b and 2l were depicted in Figure 2 and Table S1-S10. The compound 2b was
crystallized in dichloromethane and n-hexane in a monoclinic P21/c space group: a =
This article is protected by copyright. All rights reserved

11.4140 (5) Å; b = 12.8499 (6) Å; c = 17.9400 (8) Å; α = 90°; β = 95.821 (2)°; γ = 90°; V =
2617.7 (2) Å3; Z = 4 (Table S1). The selected bond lengths and bond angles were given in
Table S3. Meanwhile, the bond angle was different between N(1) and N(2) side chain:
C(12)-C(11)-N(1), 110.0(3) and N(2)-C(13)-C(14), 114.00(19).
The compound 2l was crystallized in dichloromethane and ethanol in a monoclinic P21/c
space group: a = 16.710 (3) Å; b = 10.2283 (16) Å; c = 17.708 (3) Å; α = 90°; β = 106.116
(3)°; γ = 90°; V = 2907.6(8) Å3; Z = 4 (Table S6). The bond angle of C(151)-N(11)-C (221)
and C(151)-N(21)-C(241) in 2l were both 124.0(3) which was different from 2b (Table S8).
The bond lengths of C=Se [1.843(3) and 1.842(4)] are higher than that of general C-N, C-C,
and C-O, and are equivalent to the C=Se bond length in known compounds (1.868(3)),
which are 1.84(3) (Nelson et al., 2014; Seliman et al., 2017).
3.3. Reaction with GSH and NAC
The stability of Se-NHC compounds under physiological conditions is crucial for
biological studies. Hence, the reactivity of the Se-NHC compound 2b in the presence of
1
physiologically important thiols like GSH and NAC, were measured by H NMR spectra
1
(Figure S1and S2). The results showed that none of the new peaks appeared in the H
NMR spectra with GSH and NAC during 7 days, indicating that 2b was relatively stable
1
under the environment of physiologically important thiols. The H NMR spectra of 2b in
deuteroxide was tested as a control and no significant changes were observed, indicating
that 2b was relatively stable in deuteroxide (Figure S3). Above all, we confirmed that 2b
could stay stable under physiological conditions.
This article is protected by copyright. All rights reserved

3.4 In vitro cytotoxic activities of selenium compounds (2a-2n)
Fig 3. Antiproliferative activity of Se-NHC compounds in HepG2 (A) and A2780 (B) cells at a dose of 20
μM. The results are mean ± SD of three independent experiments.
This article is protected by copyright. All rights reserved

MTT assay is known as a general experiment to validate the cytotoxicity effect of tested
compounds and it is also a classical method for screening potential anticancer agents.
Thus, in vitro cytotoxicity assays were performed by MTT assay to get an insight into the
antitumor activity of the Se-NHC compounds. Initially, we tested the antitumor activity of
Se-NHC compounds 2a-2n at the same concentration (20 μM) in HepG2 HCC cells and
A2780 ovarian cancer cells by MTT assays. As shown in Figure 3A and 3B, all Se-NHC
compounds have no inhibitory effects in HepG2 cell line while several compounds
including 2b, 2e, and 2h show good antiproliferative effects against A2780 cells. These
results indicated that there was a hint of selectivity of these Se-NHC compounds towards
A2780 cells.
Subsequently, we determined the IC50 values of 2a-2n in A2780 human ovarian cancer
cells and IOSE80 human normal ovarian epithelial cells. Ebselen was used as a positive
control. As can been seen from Table 1, several compounds (2a, 2b, 2g, 2e, 2h) exhibited
effective antitumor activity. Among them, antitumor activities of 2a, 2b and 2h were up to
2.6-fold (2a, 9.7 μM), 4-fold (2b, 6.4 μM) and 2-fold (2h, 13.0 μM) more active than ebselen
(25.4 μM). Notably, ebselen and most active compounds which exhibited effective activities
against A2780 cells showed weak cytotoxicity in IOSE80 normal cells. Above all, these
compounds performed equivalent or better selectivity towards cancer cells A2780 than
ebselen.
Hence, we have summarized an SAR study for this series of compounds. As shown in
Table 1, biphenyl Se-NHC compounds 2k, 2l and 2m as well as imidazole Se-NHC
compound 2n showed little cytotoxicity against A2780 cells compared with most
4,5-diphenylimidazole Se-NHC compounds. These results suggested that the benzene ring
at the 4 and 5 positions of the imidazole ring was necessary for bioactivity and larger steric
hindrance substituents like biphenyls could reduce the antiproliferative activity. Next,
Se-NHC compounds 2a (9.7 ± 1.41 μM), 2e (21.1 ± 2.02 μM), and 2k (>160 μM) showed
decreasing antiproliferative activitives against A2780 cells indicating that the inhibitory
activity was related to the substituents at the para position of the benzene ring (inhibitory
This article is protected by copyright. All rights reserved

activity: Ph < Br< OMe). In addition, compounds with an N(2) -aromatic chain [2b (6.4 ±
1.21 μM), 2g (19.1 ± 3.23 μM), 2h (13.0 ± 1.79 μM) except for 2c (>160 μM)] showed the
same or more active inhibitory effects than those with -aliphatic chains. These results
indicated that the aromatic ring on the N side chain played a significant role in anticancer
activities and it may be attributed to the lipophilicity of the compounds.
Table 1. Antiproliferative effects of 2a-2n against A2780 and IOSE80 Cells after 72 h of
Incubation.
IC50 (μM) Mean ± SD
Compounds
SIa
A2780
25.4 ± 2.80
9.7 ± 1.41
6.4 ± 1.21
> 160
IOSE80
55.4 ± 8.45
51.3 ± 4.86
11.0 ± 2.40
> 160
Ebselen
2a
2.18
5.30
2b
2c
1.72
-
2d
2e
> 160
> 160
-
21.1 ± 2.02
85.3 ± 8.63
19.1 ± 3.23
13.0 ± 1.79
34.6 ± 1.50
> 160
43.7 ± 3.87
> 160
2.05
2f
-
2g
2h
2i
34.8 ± 3.06
29.4 ± 2.86
43.4 ± 7.40
> 160
1.83
2.26
1.26
2j
-
-
-
-
-
2k
> 160
> 160
2l
> 160
> 160
2m
2n
> 160
> 160
> 160
> 160
a SI, Selectivity index, SI = IC50 (IOSE80) / IC50 (A2780).
These results indicated that Se-NHC compounds showed selectivity towards A2780 ovarian
cancer cells and these compounds were not sensitive in HepG2 cells. Among them, compound 2b
exhibited the best antitumor activity against A2780 cells. Moreover, all of Se-NHC compounds
This article is protected by copyright. All rights reserved

demonstrated selectivity towards A2780 human ovarian cancer cells than IOSE80 human normal
ovarian epithelial cells. The SAR studies also provide some ideas for our later design, such as
expanding the aromaticity of the substituents on the N side chain of the imidazole ring or
introducing aliphatic substituents at the para positions of the 4,5-diaryl groups which may improve
the antiproliferative activity of Se-NHC compounds.
3.5. The isolated TrxR inhibition and interaction with ct-DNA
Se compounds have been well documented to show higher selectivity and sensitivity in cancer
cells and exhibited pro-oxidant properties which can be broadly attributed to different targets such
as protein thiols and DNA binding (Gandin, Khalkar, Braude, & Fernandes, 2018). Selenoprotein
such as TrxR has been considered to be a potential target for selenium compounds (He, Ji, Lai, &
Chen, 2015; Y. W. Liang, Zheng, Li, Zheng, & Chen, 2014). Thus, we studied the TrxR inhibitory
effect and DNA binding affinity of 2b. Unexpectedly, 2b showed weak TrxR inhibitory activity (IC50
> 40 μM) on isolated enzymes using the DTNB assay in Figure 4A, indicating that TrxR is not the
potential target of 2b. Similarly, the absorption of DNA was not changed (Figure 4B) and the
configuration of DNA did not change significantly by circular dichroism (CD) assay with an
increase of 2b concentration (Figure 4C), which also indicated that DNA is not the target of these
Se-NHC compounds.
This article is protected by copyright. All rights reserved

Fig 4. Inhibition to the activity of purified TrxR by 2b (A); UV/Vis spectra (B) and CD spectra (C)
recorded for the reaction of compound 2b with ct-DNA. rb = [2b]/[ct-DNA].
The above negative results revealed that Se-NHC compounds did not directly interact with
selenoprotein or DNA to exert antitumor activity. Previous studies have shown that Se compounds
were able to alter the intracellular redox balance and a slight additional ROS induction would lead
to oxidative stress dependent cell death in tumor microenvironment (Cairns, Harris, & Mak, 2011;
Gorrini, Harris, & Mak, 2013; Khalkar et al., 2018; Selenius et al., 2012). Hence, the mechanisms
related to tumor cell apoptosis caused by elevated ROS have been another direction for us to
study the mode of action of Se-NHC compounds.
3.6. ROS analysis
Maintaining redox homeostasis is necessary for all healthy cells. The balance between
the generation of ROS and their elimination by cellular antioxidant agents plays an
important role in cellular events. In addition, the level of ROS in tumor cells is excessively
increased because of the aberrant proliferation of cancer cells (Gorrini et al., 2013; Sze et
al., 2020). It was reported that the antitumor effect of organoselenium compounds is
This article is protected by copyright. All rights reserved

related to the level of ROS (An, Zhang, et al., 2018; Deng, Yu, Cao, Zheng, & Chen, 2015;
Dos Santos et al., 2020; Fernandes & Gandin, 2015; Gandin et al., 2018; He et al., 2015; Y.
Liang, Zhou, Deng, & Chen, 2016; Misra, Boylan, Selvam, Spallholz, & Bjornstedt, 2015;
Yang, Deng, Zeng, Hu, & Chen, 2016; Zhao et al., 2017).
To investigate whether the proliferation inhibitory activity of 2b was associated with
ROS production, the level of ROS in 2b-treated A2780 cells was detected by general
methods in literature (Saleh et al., 2015). As shown in Figure 5A, A2780 cells were
incubated with 2b (10 μM, 20 μM, and 40 μM) for 12 h and the ROS production was
analyzed by fluorescence analysis. The ROS level in cells treated with 2b was higher than
control group. These findings suggested that 2b can activate ROS in a dose-dependent
manner in A2780 cells as expected. To demonstrate whether ROS was related to the
selectivity towards A2780 cells, A2780 human ovarian cancer cells and IOSE80 human
normal ovarian epithelial cells were incubated with 2b in different concentrations (2.5 μM, 5
μM, 10 μM, 20 μM and 40 μM) for 6 h and the production of ROS was measured by ROS
assay kit. As shown in Figure 5B, the production of ROS increased in a dose-dependent
manner in A2780 cells while the production of ROS in IOSE80 was not changed
significantly with the concentration increased, even under a high dose (40 μM). This result
suggested that the antitumor activity of 2b may be due to its ability to disrupt redox
homeostasis in cancer cells and induce ROS accumulation, thereby leading to oxidative
stress dependent cell death of cancer cells. Meanwhile, in normal cell IOSE80, 2b
displayed little ability to induce the accumulation of ROS and this may be the reason for its
selectivity towards A2780 cells than IOSE80.
This article is protected by copyright. All rights reserved

Fig 5. ROS generation after treatment with 2b in different concentrations for 12 h (A, original
magnification, 200 x ); ROS production of IOSE80 and A2780 after treated with 2b for 6 h (B). The ratio
of GSH/GSSG in A2780 cells treated with 2b for 24 h (C).**p < 0.01 and ***p < 0.001 compared with
group DMF.
It is well known that GSH/GSSG ratio was closely related to ROS level and it was
usually selected as an indicator for antioxidant proteins and oxidative stress. (Lu et al.,
2018). Therefore, we examined whether treatment with 2b can affect the GSH/GSSG ratio.
As shown in Figure 5C, 2b can reduce the GSH/GSSG ratio in A2780 cells. The
decreased GSH/GSSG ratio and increased production of ROS indicated that 2b could
disrupt the redox balance and lead to oxidative stress dependent cell death in A2780 cells.
3.7. MMP
This article is protected by copyright. All rights reserved

It is well known that the major source of ROS comes from mitochondrial metabolism
(Zhang, Li, Han, Liu, & Fang, 2017). The accumulation of ROS in cells can damage DNA
through oxidative stress, destroy MMP and cause mitochondrial dysfunction, which
ultimately leading to apoptosis and cell death (Bian, Fan, Zhao, & Liu, 2019; Dharmaraja,
2017; Huang et al., 2018; Pelicano, Carney, & Huang, 2004). MMP in A2780 cells treated
with 2b was tested by JC-1 kit. As shown in Figure 6, a dose-dependent decrease in MMP
was observed (red fluorescence turning green fluorescence) indicating the normal
physiological MMP was seriously damaged by 2b in 40 μM. This result suggested that 2b
can induce ROS production, damage MMP, and lead to mitochondrial dysfunction.
Fig 6. MMP imaged by JC-1 staining after treatment with 2b for 24 h (original magnification, 200 x ).
3.8. Cell cycle analysis and apoptosis
This article is protected by copyright. All rights reserved

The high level of ROS can cause oxidative stress on the cells, which may eventually lead
to cell death or apoptosis (Bian et al., 2019). Therefore, we investigated whether the ROS
production induced by 2b in the A2780 cells could lead to apoptosis. Hence, the apoptosis
of A2780 cells treated with 2b was detected by propidium iodide (PI) staining and
FITC-Annexin V staining (Fan et al., 2019). The A2780 cells were incubated with 2b for 48
h and the state of apoptosis was measured by flow cytometry. As shown in Figure 7A, the
apoptosis in 2b-treated A2780 cells was enhanced in a dose-dependent manner.
Subsequently, the cell cycle progression of 2b-treated A2780 cells was studied by PI
staining and the results showed that the cells were arrested at G0/G1 phase after
treatment for 24 h. (Figure 7B). Thus, 2b could block the A2780 cell cycle in the G0/G1
phase, and finally promote cell apoptosis.
Fig 7. Apoptosis of A2780 cells treated with 2b at different concentrations for 48 h (A); effect of 2b on
cell cycle progression (B). **p < 0.01 and ***p < 0.001 compared with group DMF.
In our previous work, NHC complexes containing different transition metals derived from
4,5-diarylimidazole can inhibit the activity of TrxR and C-terminal thiol/selenol was the
active site (Bian et al., 2020; Fan et al., 2019; Liu, Bensdorf, Hagenbach, et al., 2011; Liu,
Bensdorf, & Proetto, 2011; Liu et al., 2012). We herein further introduced Se into NHC
scaffold to synthesize fourteen Se-NHC compounds and evaluated their biological activity.
Among them, compound 2b with 2,4,6-trimethylbenzyl group on the N(2) side showed the
This article is protected by copyright. All rights reserved

most potent cytotoxicity and provided a hint of selectivity towards A2780 cells. However,
compound 2b showed weak inhibition of the isolated TrxR which did not meet our original
design and this stimulated us to search for the antitumor mechanism of Se-NHC compounds
.
Inspiringly, numbers of studies showed that Se compounds could induce ROS
accumulation and promote cell apoptosis (Khalkar et al., 2018). Consequently, compound
2b was selected for the following studies, and the action mechanism of compound 2b in
A2780 cells involved accumulation of ROS, mitochondrial dysfunction, and induction of
apoptosis.
4. Conclusion
A series of Se-NHC compounds were synthesized, characterized, and biologically investigated.
A preliminary SAR study showed that compound 2b exhibited an effective cytotoxic effect and
selectivity towards A2780 cells. However, the TrxR and DNA were not the potential targets for
Se-NHC compounds and the experiments showed that the cytotoxicity and selectivity were
attributed to apoptosis activated by ROS. Studies demonstrated that 2b mainly induced the
accumulation of ROS, damaged the MMP, blocked the cells in the G0/G1 phase, and finally
promoted A2780 cell apoptosis. All of the results indicated that 2b represents a potential candidate
for the treatment of ovarian cancer.
Appendix. Supplementary date.
The 1H NMR and 13C NMR spectrum of target compounds; the stability of 1H NMR spectrum for
2b in deuteroxide, GSH and NAC; crystallographic information of 2b and 2l.
Acknowledgments
We thank the financial supports of the National Natural Science Foundation of China
(No.81703337), the Priority Academic Program Development of Jiangsu Higher Education
Institutions (Integration of Chinese and Western Medicine), the Jiangsu Specially-Appointed
This article is protected by copyright. All rights reserved

Professors program, the Six Talent Peaks Project in Jiangsu Province of China (No. SWYY-069),
the Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of
Chinese Medicine (No. 2020YLXK010), and Postgraduate Research & Practice Innovation
Program of Jiangsu Province (No. KYCX20_1564, KYCX20_1510, SJCX20_0532). We also thank
for the experimental support from the experiment center for science and technology, Nanjing
University of Chinese Medicine.
References
An, B., Wang, B., Hu, J., Xu, S., Huang, L., Li, X., & Chan, A. S. C. (2018). Synthesis and
biological evaluation of selenium-containing 4-anilinoquinazoline derivatives as novel
antimitotic agents. J. Med. Chem., 61, 2571-2588. doi:10.1021/acs.jmedchem.8b00128
An, B., Zhang, S., Hu, J., Pan, T., Huang, L., Tang, J. C., Chan, A. S. C. (2018). The design,
synthesis and evaluation of selenium-containing 4-anilinoquinazoline hybrids as anticancer
agents and a study of their mechanism. Org. Biomol. Chem., 16, 4701-4714.
doi:10.1039/c8ob00875b
Banerjee, S., & Kaye, S. B. (2013). New strategies in the treatment of ovarian cancer: current
clinical perspectives and future potential. Clin. Cancer Res., 19(5), 961-968.
doi:10.1158/1078-0432.CCR-12-2243
Bian, M., Fan, R., Jiang, G., Wang, Y., Lu, Y., & Liu, W. (2020). Halo and pseudohalo gold(I)-NHC
complexes derived from 4,5-diarylimidazoles with excellent in vitro and in vivo anticancer
activities
against
HCC.
J.
Med.
Chem.,
63,
9197-9211.
doi:10.1021/acs.jmedchem.0c00257
Bian, M., Fan, R., Zhao, S., & Liu, W. (2019). Targeting the thioredoxin system as a strategy for
cancer therapy. J. Med. Chem., 62, 7309-7321. doi:10.1021/acs.jmedchem.8b01595
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev.
Cancer, 11, 85-95. doi:10.1038/nrc2981
Casini, A., Sun, R. W., & Ott, I. (2018). Medicinal chemistry of gold anticancer metallodrugs. Met.
Ions Life Sci., 18, 199–217. doi:10.1515/9783110470734-013
This article is protected by copyright. All rights reserved

Deng, Z., Yu, L., Cao, W., Zheng, W., & Chen, T. (2015). A selenium-containing ruthenium
complex as a cancer radiosensitizer, rational design and the important role of
ROS-mediated signalling. Chem. Commun., 51, 2637-2640. doi:10.1039/c4cc07926d
Dharmaraja, A. T. (2017). Role of reactive oxygen species (ROS) in therapeutics and drug
resistance in cancer and bacteria. J. Med. Chem., 60, 3221-3240.
doi:10.1021/acs.jmedchem.6b01243
Dos Santos, D. C., Rafique, J., Saba, S., Almeida, G. M., Siminski, T., Padua, C., . . . Ourique, F.
(2020). Apoptosis oxidative damage-mediated and antiproliferative effect of selenylated
imidazo[1,2-a]pyridines on hepatocellular carcinoma HepG2 cells and in vivo. J. Biochem.
Mol. Toxic., e22663-e22663. doi:10.1002/jbt.22663
Engman, L., Cotgreave, I., Angulo, M., Taylor, C. W., Paine-Murrieta, G. D., & Powis, G. (1997).
Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential
antitumor agents. Anticancer Res., 17, 4599-4605.
Fan, R., Bian, M., Hu, L., & Liu, W. (2019). A new rhodium(I) NHC complex inhibits TrxR: In vitro
cytotoxicity and in vivo hepatocellular carcinoma suppression. Eur. J. Med. Chem., 183,
111721-111721. doi:10.1016/j.ejmech.2019.111721
Fernandes, A. P., & Gandin, V. (2015). Selenium compounds as therapeutic agents in cancer.
Biochimica
Et
Biophysica
Acta-General
Subjects,
1850,
1642-1660.
doi:10.1016/j.bbagen.2014.10.008
Gandin, V., Khalkar, P., Braude, J., & Fernandes, A. P. (2018). Organic selenium compounds as
potential chemotherapeutic agents for improved cancer treatment. Free Radical Bio. Med.,
127, 80-97. doi:10.1016/j.freeradbiomed.2018.05.001
Garcia-Garcia, P., Martinez, A., Sanjuan, A. M., Fernandez-Rodriguez, M. A., & Sanz, R. (2011).
Gold(I)-catalyzed tandem cyclization-selective migration reaction of 1,3-dien-5-ynes:
regioselective synthesis of highly substituted benzenes. Org. Lett., 13, 4970-4973.
doi:10.1021/ol202129n
Gautier, A., & Cisnetti, F. (2012). Advances in metal-carbene complexes as potent anti-cancer
agents. Metallomics, 4, 23-32. doi:10.1039/c1mt00123j
This article is protected by copyright. All rights reserved

Gorrini, C., Harris, I. S., & Mak, T. W. (2013). Modulation of oxidative stress as an anticancer
strategy. Nat. Rev. Drug Discov., 12, 931-947. doi:10.1038/nrd4002
Gothe, Y., Marzo, T., Messori, L., & Metzler-Nolte, N. (2015). Cytotoxic activity and protein binding
through an unusual oxidative mechanism by an iridium(I)-NHC complex. Chem. Commun.,
51(15), 3151-3153. doi:10.1039/c4cc10014j
Harlepp, S., Chardon, E., Bouche, M., Dahm, G., Maaloum, M., & Bellemin-Laponnaz, S. (2019).
N-heterocyclic carbene-platinum complexes featuring an anthracenyl moiety: anti-cancer
activity and DNA interaction. Int. J. Mol. Sci., 20(17). doi:10.3390/ijms20174198
He, L., Ji, S., Lai, H., & Chen, T. (2015). Selenadiazole derivatives as theranostic agents for
simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase. J. Mater.
Chem. B, 3, 8383-8393. doi:10.1039/c5tb01501d
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A.
(2008). Mitochondria-targeted chemotherapeutics: the rational design of gold(I)
N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target
protein selenols in preference to thiols. J. Am. Chem. Soc., 130, 12570-12571.
doi:10.1021/ja804027j
Hosnedlova, B., Kepinska, M., Skalickova, S., Fernandez, C., Ruttkay-Nedecky, B., Malevu, T. D.,
Kizek, R. (2017). A summary of new findings on the biological effects of selenium in
selected animal species-a critical review. Int. J. Mol. Sci., 18, 2209-2209.
doi:10.3390/ijms18102209
Huang, K. B., Wang, F. Y., Tang, X. M., Feng, H. W., Chen, Z. F., Liu, Y. C., .Liang, H. (2018).
Organometallic gold(III) complexes similar to tetrahydroisoquinoline induce
ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells. J. Med.
Chem., 61, 3478-3490. doi:10.1021/acs.jmedchem.7b01694
Ibrahim, S. A. Z., Kerkadi, A., & Agouni, A. (2019). Selenium and health: an update on the
situation in the middle east and north africa. Nutrients, 11, 1457-1457.
doi:10.3390/nu11071457
Ip, C., Lisk, D. J., & Ganther, H. E. (1998). Activities of structurally-related lipophilic selenium
This article is protected by copyright. All rights reserved

compounds as cancer chemopreventive agents. Anticancer Res., 18, 4019-4025.
Kala, S., Mak, A. S., Liu, X., Posocco, P., Pricl, S., Peng, L., & Wong, A. S. (2014). Combination of
dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the
clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating
ovarian cancer. J. Med. Chem., 57(6), 2634-2642. doi:10.1021/jm401907z
Kamal, A., Nazari, V. M., Yaseen, M., Iqbal, M. A., Ahamed, M. B. K., Majid, A. S. A., & Bhatti, H.
N. (2019). Green synthesis of selenium-N-heterocyclic carbene compounds: evaluation of
antimicrobial and anticancer potential. Bioorg. Chem., 90, 103042-103042.
doi:10.1016/j.bioorg.2019.103042
Khalkar, P., Ali, H. A., Codo, P., Argelich, N. D., Martikainen, A., Arzenani, M. K., Fernandes, A. P.
(2018). Selenite and methylseleninic acid epigenetically affects distinct gene sets in
myeloid leukemia: A genome wide epigenetic analysis. Free Radical Biol. Med., 117,
247-257. doi:10.1016/j.freeradbiomed.2018.02.014
Lai, H., Fu, X., Sang, C., Hou, L., Feng, P., Li, X., & Chen, T. (2018). Selenadiazole derivatives
inhibit angiogenesis-mediated human breast tumor growth by suppressing the
VEGFR2-Mediated ERK and AKT signaling pathways. Chem. Asian. J., 13, 1447-1457.
doi:10.1002/asia.201800110
Li, Y., Tan, C. P., Zhang, W., He, L., Ji, L. N., & Mao, Z. W. (2015). Phosphorescent
iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic
and
photodynamic
anticancer
agents.
Biomaterials,
39,
95-104.
doi:10.1016/j.biomaterials.2014.10.070
Li, Z., Carrier, L., Belame, A., Thiyagarajah, A., Salvo, V. A., Burow, M. E., & Rowan, B. G. (2009).
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer
xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast
Cancer Res. Tr., 118, 33-43. doi:10.1007/s10549-008-0216-x
Liang, Y., Zhou, Y., Deng, S., & Chen, T. (2016). Microwave-assisted syntheses of
benzimidazole-containing selenadiazole derivatives that induce cell-cycle arrest and
apoptosis in human breast cancer cells by activation of the ROS/AKT pathway.
This article is protected by copyright. All rights reserved